Abstract
Thyroid-associated orbitopathy (TAO) is the most frequent extrathyroidal manifestation of Graves’ disease. It is an autoimmune process affecting the retrobulbar tissue. It is the most common cause of bilateral and unilateral exophthalmos among adults. The clinical presentation may vary from mild disease to severe irreversible sight-threatening complications. Till date, TAO remains a major diagnostic and therapeutic challenge. Diagnosis of orbitopathy is mainly clinical and treatment is based on the clinical severity of the disease. In this article, we review the pathophysiology, epidemiology, classification, clinical presentation, and management of this common yet challenging orbital inflammatory disease.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
